Xeris Biopharma Holdings (XERS) Other Non-Current Assets (2020 - 2026)
Xeris Biopharma Holdings' Other Non-Current Assets was $5.03 million in Q2 2026, down 0.7% from $5.06 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Xeris Biopharma Holdings came in at $5.22 million, down 3.5% from FY2024.
- Other Non-Current Assets shows a five-year compound annual growth rate of 86.4% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $5.41 million in FY2024 (+19.1%), $4.54 million in FY2023 (-4.0%), $4.73 million in FY2022 (+470.6%) and $829,000 in FY2021 (+257.3%).
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Assets since Q1 2024.
- Compared with a year earlier, Other Non-Current Assets was higher in four of the last eight quarters, with growth averaging 3.6%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q3 2022 (growth of 928.4%); the worst was Q2 2025 (a decline of 7.9%).
- Per Business Quant data, XERS's Other Non-Current Assets in the three quarters before Q2 2026 was $5.12 million (Q1 2026), $5.22 million (Q4 2025) and $5.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Xeris Biopharma Holdings | 1.66 Bn | 1.22 Bn | 79.59 Mn | 5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 5.22 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Sep 30, 2024 | 5.44 Mn |
| Jun 30, 2024 | 5.49 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Jun 30, 2023 | 4.81 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 2.17 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 829,000.00 |
| Sep 30, 2021 | 211,000.00 |
API Access
Xeris Biopharma Holdings Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();